DeepRhythmAI vs AVIEW

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Medicalgorithmics
VS
by Coreline Soft Co.

AI Verdict

DeepRhythmAI is specialized in cardiac arrhythmia detection and classification from ECG data, focusing on the electrical activity of the heart. AVIEW, conversely, offers comprehensive AI solutions for CT scans, primarily addressing lung conditions like cancer and COPD, but also includes coronary artery calcification scoring for structural heart health assessment. While both contribute to cardiac diagnostics, they utilize different data modalities and target distinct clinical problems within cardiology.

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your primary need is highly accurate and efficient AI-driven analysis of ECG data for cardiac arrhythmia detection and classification. This tool is ideal for cardiology practices and health systems aiming to significantly reduce missed diagnoses and streamline their ECG reporting workflows with superior AI-powered insights.

View DeepRhythmAI →

Choose AVIEW if…

Choose AVIEW if your focus is on comprehensive AI-driven analysis of CT scans for the early detection, diagnosis, and monitoring of multiple thoracic conditions, including lung cancer, COPD, and coronary artery calcification. This platform is best suited for radiology departments and pulmonology specialists requiring detailed quantification, 3D visualizations, and seamless integration into existing imaging workflows.

View AVIEW →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature DeepRhythmAI AVIEW
Pricing Contact vendor for pricing information Subscription; one-off payment
Deployment Cloud-based, hardware-agnostic, SaaS, on-prem, hybrid Cloud-based; Hybrid solution; Locally on dedicated hardware; Locally virtualized (virtual machine, Docker)
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature DeepRhythmAI AVIEW
Primary Focus Cardiac arrhythmia detection and classification from ECG data. Early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans.
Company Medicalgorithmics S.A. Coreline Soft Co.
API Available yes Not specified
Specialties Cardiology Cardiology, Pulmonology, Radiology
Key AI Capabilities AI-powered arrhythmia detection and classification, utilizes CNN and Transformer models, trained on 250 billion+ annotated heartbeats, device-agnostic. AI-powered lung nodule detection and characterization, emphysema quantification, coronary artery calcium (CAC) scoring, automated segmentation, 3D visualizations, ILD pattern analysis.
Target Customer Size Solo to large health systems Not specified
Headquarters Warsaw, Poland Not specified

Videos

Demos, reviews, and walkthroughs featuring DeepRhythmAI and AVIEW.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

DeepRhythmAI is designed for cardiac arrhythmia detection and classification from ECG data, primarily serving cardiology. AVIEW offers comprehensive solutions for the early detection, diagnosis, and monitoring of lung cancer, COPD, and coronary artery calcification from CT scans, supporting cardiology, pulmonology, and radiology specialties.
DeepRhythmAI analyzes ECG data for cardiac arrhythmia detection. AVIEW analyzes CT scans for conditions related to lung cancer, COPD, and coronary artery calcification.
DeepRhythmAI is device-agnostic and integrates with various ECG devices, also offering an API. AVIEW provides workflow automation and integration with PACS/RIS/CIS.
DeepRhythmAI offers AI-powered arrhythmia detection and classification, utilizing CNN and Transformer models trained on over 250 billion annotated heartbeats. AVIEW provides AI-powered lung nodule detection and characterization, emphysema quantification, coronary artery calcium scoring, automated segmentation, and ILD pattern analysis from CT scans.
DeepRhythmAI offers superior accuracy and efficiency, faster ECG reporting, reduces missed diagnoses (14x to 114x fewer), and streamlines clinical workflows (up to 65% efficiency increase). AVIEW enhances diagnostic precision and streamlines radiology workflows.
AI Tool Finder
AI-powered search. Results may not be comprehensive.